US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
CVS Health (NYSE:CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...
The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...
We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...
This week's dividend activity included increased payouts from Microsoft (NASDAQ:MSFT) and JPMorgan (NYSE:JPM) as well as ...
CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.
Oak Street Health, a subsidiary of CVS, is paying $60 million to the federal government to resolve allegations that it ...
CVS Health's strategy to pivot into health services failed due to lack of experience and market complexity. See why I ...
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback